4 more presentations in this session
Next generation drugs for atrial fibrillation in humans - Good new chemistry
Speaker: Professor D. Dobrev (Essen, DE)
Molecular therapy for genetic arrhythmogenic diseases - A white coats' tandem
Speaker: Professor S. Priori (Pavia, IT)
Biological shockless defibrillation - True translational challenges
Speaker: Professor D. Pijnappels (Leiden, NL)
Access the full session
Exploration of novel anti-fibrillatory strategies - A joint PhD-MD effort
Speakers:
Professor D. Dobrev, Professor S. Priori, Professor D. Pijnappels, Professor I. Efimov
About the event
ESC 365 is supported by
